RYTM vs SO · rev $130.1M vs P/E 22, rev $29.55B
Rhythm Pharmaceuticals Inc (RYTM) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
RYTM currently screens at market cap $6.49B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the RYTM and SO stock pages for the full models.
Not investment advice.